The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy

Brain and Language

Volumn 52, Issue 10, 1997, Pages 787-790

  Taylor, H M ^a   Bingham, J B ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFIXIME; CEFRADINE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEVER; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRELAND; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE BIOPSY; RECTAL DRUG ADMINISTRATION; STANDARDIZATION; TRANSRECTAL ULTRASONOGRAPHY; UNITED KINGDOM; URINARY TRACT INFECTION;

EID: 23744486673     PISSN: 0093934X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9260(97)80161-4     Document Type: Article

References (18)

1. Bissada NK, Rountree GA, Suleiman JS. Factors affecting accuracy and morbidity in transrectal biopsy of the prostate. Surgery, Gynecology and Obstetrics 1977;145:869-872.
2. Crawford ED, Haynes AL Jr, Story MW et al. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. Journal of Urology 1982;127:449-451.
3. Davison P, Malament M. Urinary contamination as a result of transrectal biopsy of the prostate. Journal of Urology 1971;105:545-546.
4. Fawcett DP, Eykyn S, Bultitude MI. Urinary tract infection following trans-rectal biopsy of the prostate. British Journal of Urology 1975;47: 679-681.
5. Ruebush TK, II, McConville JH, Calia FM. A double-blind study of trimethoprim-sulfamethoxazole prophylaxis in patients having trans-rectal needle biopsy of the prostate. Journal of Urology 1979;122:492-494.
6. Ashby EC, Rees M, Dowding CH. Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma. British Medical Journal 1978;2:1263-1264.
7. McGinnis DE, Gomella LG. Tumors of the prostate. In: RR Bahnson, ed. Management of Urologic Disorders, 1st ed. London: Wolfe Publishing, 1994;5.5.
8. Charig CR. Ultrasound-guided techniques. In: PJR Shah, ed. Prostate Outflow Obstruction: Clinical Investigation and Treatment, 1st ed. Oxford: Blackwell Science Ltd, 1995:39-40.
9. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, 1996;31:230-250.
10. Brewster SF, MacGowan AP, Gingell JC. Antimicrobial prophylaxis for transrectal prostate biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. British Journal of Urology 1995;76:351-354.
11. Thompson PM, Pryor JP, Williams JP et al. The problem of infection after prostate biopsy: the case for the transperineal approach. British Journal of Urology 1982;54:736-740.
12. Sharpe JR, Sadlowski RW, Finney RP et al. Urinary tract infection after transrectal needle biopsy of the prostate. Journal of Urology 1982;127:255-256.
13. Harris LF, Jackson RT, Breslin JA Jr et al. Anaerobic septicemia after transrectal prostatic biopsy. Archives of Internal Medicine 1978;138: 393-395.
14. Brewster SF, Rooney N, Kabala J et al. Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumour. British Journal of Urology 1993;77:977-978.
15. Roach MB, Figueroa TE, McBride D et al. Ciprofloxacin versus gentamicin in prophylaxis against bacteraemia in transrectal prostate needle biopsy. Urology 1991;38:84-87.
16. Fong IW, Struthers N, Honey RJ et al. A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole in transrectal prostatic biopsy. Journal of Urology 1991;146:794-797.
17. Warren RE. Antibacterial agents: the fluoroquinolones. Prescribers' Journal 1995;35(2):95-101.
18. Anjum MI, Palmer JH, Mufti GR. Antimicrobial prophylaxis for transrectal prostatic biopsy (letter). British Journal of Urology 1996;77:618-619.